The Sudden Cardiac Arrest Association is the nation's largest public advocacy organization singularly dedicated to sudden cardiac arrest (SCA) awareness and prevention. Its network of chapters, affiliates and volunteers include SCA survivors, patients at risk, physicians, nurses, EMTs and others touched by SCA. SCAA and its members work to expand public knowledge of SCA, improve emergency response to SCA victims, and encourage access to preventative medical care to patients at risk.

For more information, please visit www.suddencardiacarrest.org.

The RecordAF registry is a unique worldwide initiative dedicated to the improvement of the management of atrial fibrillation (AF) in day-to-day clinical practice. Join Dr Peter Kowey's presentation to learn about the design, rationale, objectives and expected outcomes of the first large-scale international prospective registry on atrial fibrillation.

Diabetes morbidity and mortality are attributed to vascular complications, both macrovascular (myocardial infarction and stroke) and microvascular (retinopathy and nephropathy). Epidemiologic data confirms a strong positive correlation between systolic blood pressure and the risk of these complications. Join our faculty as they present the results of the ADVANCE trial, the largest trial to date of patients with type 2 diabetes, which was designed to determine if tighter control of blood pressure lowering and close management of glucose levels would reduce the risk of all complications in adults with type 2 diabetes. Featuring Drs Fox, Chalmers, MacMahon, Marre, and Poulter.

Join chair Dr Mohammed Balghith and experts for a case-based presentation on learning to apply the right technique and equipment for specific coronary intervention cases, and to rapidly identify complications during the intervention and act accordingly. Experts include Drs Waqar Habib, Mohamed Arafa, Mohammed Kurdi, Abdullateef Y Khoja, and Layth A Mimish.